.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Healthtrust
AstraZeneca
Cantor Fitzgerald
Baxter
Cerilliant
Farmers Insurance
Mallinckrodt
UBS
Deloitte

Generated: June 25, 2017

DrugPatentWatch Database Preview

Capreomycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for capreomycin sulfate and what is the scope of capreomycin sulfate freedom to operate?

Capreomycin sulfate
is the generic ingredient in one branded drug marketed by Akorn and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for capreomycin sulfate. One supplier is listed for this compound.

Summary for Generic Name: capreomycin sulfate

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Clinical Trials: see list640
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:capreomycin sulfate at DailyMed

Pharmacology for Ingredient: capreomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
CAPASTAT SULFATE
capreomycin sulfate
INJECTABLE;INJECTION050095-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Baxter
US Army
UBS
McKinsey
QuintilesIMS
Dow
Novartis
Queensland Health
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot